Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06769386

Investigation of Muscle Oxygenation in Patients With Rheumatoid Arthritis

The aim of this study is to investigate respiratory muscle strength, respiratory muscle endurance, muscle oxygenation, upper extremity and lower extremity exercise capacity in rheumatoid arthritis patients compared with healthy individuals.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Kırşehir Ahi Evran University, Physical Therapy and Rehabilitation Center, Cardiopulmonary Unit

Kırşehir, Merkez, 40100, Turkey (Türkiye)

Location status: Recruiting

Location contact

Başak KAVALCI KOL, PhD

CONTACT

[email protected]

+903862802317

About this study

Rheumatoid arthritis (RA) is a chronic progressive autoimmune disease of unknown etiology with symmetric erosive synovitis and multisystem involvement. The disease causes significant long-term morbidity, reduced functional capacity, and increased mortality rates. Patients with rheumatoid arthritis avoid physical activity due to pain and fatigue. Despite the advances in pharmacological treatments in recent years, functional losses due to rheumatic diseases the resulting deterioration in quality of life, and loss of work continue. Physical inactivity is known to have detrimental effects on the cardiovascular and pulmonary systems by reducing muscle strength and aerobic capacity. The physiological reasons underlying skeletal muscle oxygenation that may cause muscle dysfunction in rheumatoid arthritis have not been investigated. In these patients, decreased arterial oxygen may reduce exercise capacity and cause muscle deoxygenation.

In rheumatoid arthritis patients, decreases in respiratory muscle strength, lung volumes, oxygen consumption, and six minute walk test distance cause cardiopulmonary deconditioning. Decreased exercise capacity increases the risk of cardiovascular disease and causes mortality in patients with RA.

This study aimed to, the effects of respiratory muscle strength, respiratory muscle endurance, upper and lower extremity muscle oxygenation, and upper and lower extremity exercise capacity in patients with stable disease activity.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Rheumatoid Arthritis Group

Inclusion criteria

  • Patients diagnosed with rheumatoid arthritis,
  • The ages of 18-65 years,
  • Volunteer to participate in the study will be included in the study.

Exclusion criteria

  • Serious cardiopulmonary, neurological, neuromuscular, orthopedic and other systemic diseases or other diseases affecting physical functions,
  • Participated in a planned exercise program in the last three months,
  • Cognitive impairment that will cause difficulty in understanding and following exercise test instructions,
  • Contraindications to exercise testing or exercise training according to the American Sports Medicine Association will not be included in the study.

Control Group

Inclusion criteria

  • The ages of 18-65 years,
  • Volunteer to participate in the study will be included in the study.

Exclusion criteria

  • Diagnosed chronic or systemic disease,
  • Regular exercise (physical activity) 3 days a week, 150 minutes/week of moderate intensity
  • Smoking 10 packs x years or more,
  • Pneumonia or any acute infection,
  • Healthy individuals with any psychiatric disorder will not be included in the study.

Treatment and study plan

Primary outcomes

  1. Evaluation of respiratory muscle strength

    Time frame: First day

    An electronic mouth pressure measuring device that complies with American Thoracic Society and European Respiratory Society criteria will be used to assess respiratory muscle strength.

  2. Evaluation of respiratory muscle endurance

    Time frame: First day

    The incremental threshold workload test will be used to assess respiratory muscle endurance.The PowerBreathe Wellness® (HaB International Ltd. Southam, United Kingdom) inspiratory muscle training device will be used in the incremental threshold load test.

  3. Evaluation of Deltoid and Quadriceps Femoris Muscle Oxygenation

    Time frame: First and second day

    Muscle oxygen level of quadriceps femoris and deltoid muscles will be measured using Moxy® monitor (Moxy, Fortiori Design LLC, Minnesota, USA) before, during and after the six-minute walk test and six-minute peg-board and ring test.

  4. Evaluation of Deltoid and Quadriceps Femoris Muscle Total Hemoglobin Level

    Time frame: First and second day

    Total hemoglobin level of quadriceps femoris and deltoid muscles will be measured using Moxy® monitor (Moxy, Fortiori Design LLC, Minnesota, USA) before, during and after the six-minute walk test and six-minute peg-board and ring test.

Secondary outcomes

  1. Evaluation of submaximal exercise capacity

    Time frame: First day and second day

    The six-minute walk test will be performed according to American Thoracic Society criteria to evaluate functional exercise capacity.

  2. Evaluation of upper extremity capacity

    Time frame: First day and second day

    The six-minute peg board and ring test will be used to assess upper extremity exercise capacity.

Study contacts

Contact information is provided by the study sponsor or research team.

Başak KAVALCI KOL, PhD

CONTACT

[email protected]

+903862802317

Sponsors and collaborators

Lead sponsor

Kirsehir Ahi Evran Universitesi

Other

Registry information

Official study title

Investigation of Respiratory Muscle Strength, Respiratory Muscle Endurance and Muscle Oxygenation in Patients With Rheumatoid Arthritis

Important dates

Study start
2025
Primary completion
2026
Study completion
2027
First posted
Jan 10, 2025
Registry last updated
Feb 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.